![]() |
![]() |
![]() |
![]() |
1-EP | Post Transplant Cyclophosphamide as a Cost Effective Innovation to Advance Transplantation in Advanced Hematological Malignancies. | Mohmad Shahnawaz Beg | ![]() |
![]() |
|||
3-EP | Diagnostic utility of Whole genomic sequencing in acute leukaemia | DANUSHKA DISSANAYAKA | ![]() |
![]() |
|||
5-EP | Prevalence of IKZF1 deletions in Tunisian pediatric acute lymphoblastic leukemia | Rim Frikha | ![]() |
![]() |
|||
6-EP | Targeting Senescence as a Promising Therapy for Chemoresistance in Paediatric Acute Myeloid Leukaemia | Aya Gouma | ![]() |
![]() |
|||
8-PP | Empagliflozin Impact on Outcomes of -Thalassemia Major Patients With Type 2 Diabetes: The THALEMPA Study | Anas Ibraheem | ![]() |
![]() |
|||
8-EP | Improving Patient Experience and Hospital Efficiency through Ambulatory Care in SCT/CAR-T Treatment | Rebecca Hallam | ![]() |
![]() |
|||
9-EP | Surge in Acute Promyelocytic Leukaemia Cases Presenting to University Hospitals of North Midlands: Population-based analysis | Romario Hamid | ![]() |
![]() |
|||
10-EP | Platelet support in patients receiving different types of allogeneic haematopoietic stem cell transplants. | Orna hogan | ![]() |
![]() |
|||
11-EP | Real-World Treatment Patterns and Outcomes in AML Patients Treated with Venetoclax in Great Britain (ARC) | Sophie Barnwell | ![]() |
![]() |
|||
13-EP | Philadelphia Positive ALL - Transplant v No Transplant a 10 Year West Of Scotland Review | steven leak | ![]() |
![]() |
|||
14-EP | Ten Years of T-Cell Acute Lymphoblastic Leukaemia/Lymphoma (T-ALL/LBL) - A West of Scotland Perspective | steven leak | ![]() |
![]() |
|||
15-PO | Pulmonary Vein Thrombosis in a pregnant woman known to have SLE and Factor XI deficiency | Zain Khan Tareen | ![]() |
![]() |
|||
15-EP | Childhood B-cell lymphoblastic leukemia accompanied by intrachromosomal amplification of chromosome 21:case report and literature review | Jiantuo Liu | ![]() |
![]() |
|||
16-EP | Real World Outcomes of AML Patients with flt3 mutations using Midostaurin as per Ratify protocol. | Deepak Mannari | ![]() |
![]() |
|||
17-EP | The development of a womens health clinic for women post stem cell transplant | Maria Mazza | ![]() |
![]() |
|||
20-EP | Moving Cycle 1 of Venetoclax/Azacytadine (Ven/Aza) to Ambulatory Care (AC) | Sarah Mohamed | ![]() |
![]() |
|||
21-EP | Stem Cell Transplantation As A Therapeutic Approach In Pediatric Refractory Leukemia: A Case Study | Purshotam Paudel | ![]() |
![]() |
|||
22-EP | A Case of Near-ETP-ALL in an Adult: Diagnostic Nuances and Multidisciplinary Insights | Milly Payne | ![]() |
![]() |
|||
23-EP | A single center experience in AML registry-pilot phase | Walaa Saad | ![]() |
![]() |
|||
24-EP | QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITDNegative Acute Myeloid Leukemia | Heather Hubbard | ![]() |
![]() |
|||
25-EP | Revised 2024 ELN Risk Classifications in Low-Intensity AML: Do they help in the real world? | Cristina M. Thiebaud | ![]() |
![]() |
|||
26-EP | Chromosomal abnormalities during the clinical course of Acute Leukemia | ZOTOVA OLENA | ![]() |
![]() |
|||
28-EP | Therapeutic Impact of BET Inhibition on Immune Cell Death Checkpoints in MPN | Niloofar Amirian | ![]() |
![]() |
|||
29-EP | Toxic Epidermal Necrolysis: A Rare Cutaneous Adverse Reaction To Lenalidomide | Ciara Bansal | ![]() |
![]() |
|||
30-EP | Bomedemstat Versus Hydroxyurea in Essential Thrombocythemia Naive to Cytoreductive Therapy: Phase 3 Shorespan-007 Study | Charlotte Brennan | ![]() |
![]() |
|||
31-EP | A rare paediatric case of myeloid/lymphoid neoplasm with platelet-derived growth factor receptor beta (PDGFRB) rearrangement | Joanna Fawcett | ![]() |
![]() |
|||
32-EP | Metabolism of Amino Acids as a Therapeutic Target and Predictor of Leukaemia Patient Outcome | Elena-Simona Gheban | ![]() |
![]() |
|||
34-EP | Cutaneous Manifestation of a Rare Haematological Malignancy: Blastic Plasmacytoid Dendritic Cell Neoplasm | Syeda Liaba Hassan | ![]() |
![]() |
|||
35-EP | Modifying Cardiovascular risk factors for patients on Tyrosine Kinase Inhibitors: sharing our improved practice | Anna Elliott | ![]() |
![]() |
|||
36-EP | Gender and Treatment Impact on Chronic Myeloid Leukaemia Outcomes: Patient-Reported Outcomes and Wearable Data Insights | Ashley Lai | ![]() |
![]() |
|||
37-EP | Outcomes in patients with Advanced phase Myeloproliferative Neoplasm treated with Ruxolitinib and 5-Azacytidine combination therapy | Wai Ka Natalie Leung | ![]() |
![]() |
|||
38-EP | Demographic, Clinical and Molecular Landscape of Myeloid Malignancies in a Developing Country: A Pilot Study | Wai Feng Lim | ![]() |
![]() |
|||
39-EP | Molecular Signature of Myeloid Malignancies in a Developing Country: 22-gene Next-Generation Sequencing Panel | Wai Feng Lim | ![]() |
![]() |
|||
40-EP | VENETOCLAX AND AZACITIDINE TREATMENT IN AML BARRIERS TO OUTPATIENT MANAGEMENT | Ben Macleod | ![]() |
![]() |
|||
41-EP | Management of chronic myeloid leukaemia in the UK: Results from the ADAPT 2.0 survey | Vanesa Martinez Lopez | ![]() |
![]() |
|||
42-EP | Spectrum of BCR::ABL1 Tyrosine Kinase Domain mutations in Imatinib Resistant Chronic Myeloid Leukaemia Patients. | Ahmed Ibrahim | ![]() |
![]() |
|||
43-EP | Primary Thrombocytosis in Children | Dr. Chikosolu Yvonne Okiche | ![]() |
![]() |
|||
44-EP | The bone marrow T-cell receptor repertoire does not predict treatment-free remission in chronic myeloid leukaemia | Shaun David Patterson | ![]() |
![]() |
|||
45-PP | Nemtabrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Open-Label, Phase 3 BELLWAVE-010 Study | Charlotte Brennan | ![]() |
![]() |
|||
46-PP | Nemtabrutinib in Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Phase 3 BELLWAVE-011 Study | Charlotte Brennan | ![]() |
![]() |
|||
46-EP | Evaluating Metabolic and Autophagic Changes in Imatinib-Resistant Chronic Myeloid Leukemia Cells | Ezzahra Rachid | ![]() |
![]() |
|||
47-EP | Review of Post-marketing Safety Data for EPYSQLI (SB12), Biosimilar to Reference Eculizumab, in Pregnant Women | Roochi Trikha | ![]() |
![]() |
|||
49-EP | Double-Class Exposed Patient and Carer Experiences of Living with Multiple Myeloma | Noreen Ali | ![]() |
![]() |
|||
50-EP | Newly Diagnosed Patient and Carer Experiences of Living with Multiple Myeloma | Noreen Ali | ![]() |
![]() |
|||
51-EP | Challenges hinder compliance with BSH recommendations for diagnosis and treatment of transplant-eligible high-risk myeloma patients | Peter Bennett | ![]() |
![]() |
|||
52-EP | The Source of Heart and Circulatory Disease and Related Events in Myeloma: A Systematic Review | Romi Carriere | ![]() |
![]() |
|||
53-EP | Optimising the diagnostic pathway for myeloma patients in a tertiary haematology centre | Richard Cassar White | ![]() |
![]() |
|||
55-EP | Spinal Involvement in Multiple Myeloma: a Comparison of Current Practise in CAVUHB with NICE Guidelines | Anest Edwards | ![]() |
![]() |
|||
57-EP | Risk Stratification in Multiple Myeloma in the UK A mixed methods study | Sarah Galley | ![]() |
![]() |
|||
58-PP | A Matching-Adjusted Indirect Comparison: Loncastuximab Tesirine versus Glofitamab in Relapsed/ Refractory DLBCL | Koo Wilson | ![]() |
![]() |
|||
59-EP | Establishing a Joint Renal-Haematology Service for Monoclonal Gammopathy of Renal Significance: A Feasibility Study | Gerard Gurumurthy | ![]() |
![]() |
|||
60-EP | Patient and Staff Experience of Ambulatory BCMA T-cell Engager Antibody Step-up Dosing: The Leeds Experience | Lindsay Hankey | ![]() |
![]() |
|||
61-EP | Dara-RVd in Newly Diagnosed Multiple Myeloma: Real-World Clinical Practice Interim Data | Stanislav Kamyshanov | ![]() |
![]() |
|||
62-EP | MRD-Adaptive Strategy as the Therapeutic Approach for Newly Diagnosed Multiple Myeloma: Precursory Results | Stanislav Kamyshanov | ![]() |
![]() |
|||
63-EP | Evaluating Monoclonal Gammopathy of Undetermined Significance Referral Accuracy: Reducing Over- and Under-Referrals | Moein Karbalaeian | ![]() |
![]() |
|||
63-PP | Iptacopan demonstrates long-term efficacy and safety in patients with paroxysmal nocturnal haemoglobinuria (PNH):APPLY_PNH | Austin Kulasekararaj | ![]() |
![]() |
|||
64-EP | Rethinking Monoclonal Gammopathy of Undetermined Significance Follow-up: Strengthening Guideline Compliance and Reducing Secondary Care Burden | Moein Karbalaeian | ![]() |
![]() |
|||
65-EP | Deliverability of D-VTd in the Treatment of Multiple Myeloma | Harry Kneale | ![]() |
![]() |
|||
66-EP | Impact of Argentinian Tango on Psychological Well-being and Clinical Outcomes in Patients with Multiple Myeloma | Pavel KOTOUCEK | ![]() |
![]() |
|||
67-EP | Impact of Elranatamab on Immunoglobulin Levels in a Real-World Multiple Myeloma Patient Cohort | Craig Lennie | ![]() |
![]() |
|||
68-EP | Optimizing Monoclonal Gammopathy of Undetermined Significance follow-up care:Review of Data from a Tertiary Hematology Centre | Soe Maung | ![]() |
![]() |
|||
68-PP | Retrospective analyses of NLPHL outcomes in the Thames Valley | Xiao-Yin Zhang | ![]() |
![]() |
|||
69-EP | Semi-automated patient videos to address knowledge gaps regarding anti-coagulation with immunomodulatory drugs in multiple myeloma | Kathryn McVinnie | ![]() |
![]() |
|||
70-EP | The Efficacy of Bortezomib-Based Regimen on Responses and Survival in Newly Diagnosed Multiple Myeloma patients | Ahmed Ibrahim | ![]() |
![]() |
|||
71-EP | Vaccination uptake among myeloma patients diagnosed in 2022 and 2023 within a major healthcare system. | Chinedu Onwuatuogwu | ![]() |
![]() |
|||
72-EP | Quality Improvement Project on Rationalising Investigation and Follow-Up for Monoclonal Gammopathy of Undetermined Significance Patients | Sohum Patel | ![]() |
![]() |
|||
73-EP | Uncovering Disparities and Opportunities: Identifying CAR T Therapy-Eligible patients in a Real-World Multiple Myeloma Population | Louise Potter | ![]() |
![]() |
|||
74-PP | Lotis-5: Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in R/R DLBCL | Pamela Mckay | ![]() |
![]() |
|||
74-EP | Developing a method evaluating quality-of -life of patients living with monoclonal gammopathy of undefined significance | indra ramasamy | ![]() |
![]() |
|||
75-EP | Introduction of a semi-automated monoclonal protein risk stratification process: a Rotherham experience | James Taylor | ![]() |
![]() |
|||
78-EP | Hodgkin Lymphoma in Older Patients (HoOP)- A Retrospective Study | Aising Barrett | ![]() |
![]() |
|||
79-EP | 18F-FDG-PET scanning following T-cell deplete RIC allogeneic transplantation for relapsed Hodgkin Lymphoma: a single-centre experience | Adrian Bloor | ![]() |
![]() |
|||
80-EP | The Role of Novel Thienopyridine Compounds as Anti-Cancer Agents via Disruption of the Cell Cycle | Christopher Broughton | ![]() |
![]() |
|||
81-EP | Efficacy and tolerability of Pola-R-CHP versus R-CHOP in first-line DLBCL treatment: A Real-World data review | Victoria Calvert | ![]() |
![]() |
|||
82-EP | Epcoritamab Monotherapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: EPCORE CLL-1 Expansion and Optimization Data | Kayla Smull | ![]() |
![]() |
|||
83-EP | Introducing Bi-Specific Antibody Therapy in managing high-grade B-Cell Non-Hodgkins Lymphoma in a Regional Service | Ewan Deans | ![]() |
![]() |
|||
84-EP | Outcomes for relapsed/refractory DLBCL patients aged =80 years treated with Polatuzumab Vedotin, Bendamustine and Rituximab | Amie Drinkwater | ![]() |
![]() |
|||
85-EP | Prehabilitation improving lymphoma outcomes | Rona Eade | ![]() |
![]() |
|||
86-EP | Survivorship Clinic Improves Trans-thoracic Echocardiogram Follow up for Anthracycline Induced Cardiomyopathy | zac forbes | ![]() |
![]() |
|||
87-EP | Contemporary Therapy Outcomes with Brentuximab Vedotin, Bendamustine and Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma. | Mia Giles | ![]() |
![]() |
|||
89-PP | KEYNOTE-B68 Update: Pembrolizumab Every 6 Weeks in Classic Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma | Charlotte Brennan | ![]() |
![]() |
|||
90-PP | WAVELINE-003: Zilovertamab Vedotin Plus Standard of Care in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Charlotte Brennan | ![]() |
![]() |
|||
90-EP | LOTIS-7: Phase 1b Study of Loncastuximab Tesirine with other agents in relapsed/refractory B-cell NHL | Katja Fraser | ![]() |
![]() |
|||
91-EP | A Retrospective study Evaluating Management of T-cell Large Granular Lymphocytic Leukaemia in a University Hospital | Mohammad Kamrul Hassan Majumder | ![]() |
![]() |
|||
92-EP | Secondary HLH in a paediatric patient with trisomy 21: a tortuous diagnostic journey. | Michail Matalliotakis | ![]() |
![]() |
|||
93-EP | Defining Fitness and Understanding Frontline Treatment Choice in Chronic Lymphocytic Leukaemia: A Modified Delphi Panel | Talha Munir | ![]() |
![]() |
|||
94-EP | A Retrospective Study of Prevalence of CXCR4 Mutations in Patients with Waldenstroms Macroglobulinemia in Singapore | AMAZE JOY TULLAO ONG | ![]() |
![]() |
|||
95-EP | A Case Report Showing Low-dose Ciclosporin Can Successfully Treat Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma | Neil Chauhan | ![]() |
![]() |
|||
96-EP | Differences in healthcare resource utilisation between 3L DLBCL treatments: A UK HCP survey | Molly Paffett | ![]() |
![]() |
|||
97-EP | Bleeding and Thrombotic Events Following CAR T Cell Therapy: A Three-Year Single-Centre Retrospective Study | Sohum Patel | ![]() |
![]() |
|||
99-EP | Retrospective review of radiologically identified lymphadenopathy. | Elizabeth Ryan | ![]() |
![]() |
|||
100-EP | Retrospective Review of Real-World Data on Use of R-POLA-CHP Chemotherapy for Large B Cell Lymphoma | Hannah Sadler | ![]() |
![]() |
|||
101-EP | Splenectomy Links Guillain-Barré Syndrome, Autoimmune Haemolysis and EBV viraemia: Unveiling a Hidden Diagnosis | Pranav Santhosh Kumar | ![]() |
![]() |
|||
101-PP | Diagnostics and Monitoring in Chronic Myeloid Leukaemia Treatment in the UK: ADAPT 2.0 Survey | Darina Hickey | ![]() |
![]() |
|||
102-EP | Retrospective study evaluating diagnostic criteria of T-cell Large Granular Lymphocytic Leukaemia in a University Hospital | Htet Htet Myo Set | ![]() |
![]() |
|||
103-EP | Therapeutic Equivalence of Biosimilar and Innovator Rituximab in Non-Hodgkins Lymphoma: A Systematic Review and Meta-analysis | Nitin Sood | ![]() |
![]() |
|||
104-EP | Proposed Standard of Care for Active Monitoring in Waldenström Macroglobulinemia From a UK-Wide Patient-Expert Collaboration | G. Isabella | ![]() |
![]() |
|||
105-EP | Monitoring Cardiovascular Risk Factors for patients on Bruton Tyrosine Kinase Inhibitors sharing improvements in practice. | Anna Elliott | ![]() |
![]() |
|||
106-EP | Challenges to establishing a tafasitamab compassionate use scheme in an NHS trust: a pharmacy review | Clayton Wong | ![]() |
![]() |
|||
107-PP | VAYHIT3: Phase 2 Study of Ianalumab in Previously Treated Patients With Primary Immune Thrombocytopenia | Nichola Cooper | ![]() |
![]() |
|||
109-EP | Infantile Giant Cell Hepatitis with Autoimmune Hemolytic Anemia in a Sri Lankan Infant | Arunath Visvalingam | ![]() |
![]() |
|||
110-EP | Genetic Analysis using the R92 Panel of Rare Anaemia and Referral Submission Quality | Jessica Coyle | ![]() |
![]() |
|||
111-EP | Pain management in Sickle Cell Disease, Audit of Fluid and Analgesia therapy (PACIFY study) | Michael Egolum | ![]() |
![]() |
|||
112-PP | Efficacy and safety of intensive pegcetacoplan dosing for the treatment of acute haemolysis in patients with paroxysmal nocturnal haemoglobinuria | Sana Yaar | ![]() |
![]() |
|||
113-EP | Antenatal haemoglobinopathy screening: Opportunity for Targeted Newborn Screening for Sickle Cell Disease in Northern Nigeria | Adama Ladu | ![]() |
![]() |
|||
116-EP | The Complex Relationship Between Iron Deficiency Anaemia and Sickle Cell Disease | Helena Usuanlele | ![]() |
![]() |
|||
117-EP | Comparing paediatric sickle cell pain protocol adherence with national and trust guidelines in A&E. | Yang Yang Wang | ![]() |
![]() |
|||
118-EP | Using wearable health monitors in cancer research: Lessons from the EMBRaCE-GM study. | Mona Asslan | ![]() |
![]() |
|||
120-EP | The influence of Knowledge, Attitudes and Practice on adherence to SCD Guidelines: a scoping review | Mmamulatelo Siame-Mumba | ![]() |
![]() |
|||
121-EP | Treatment Escalation Plan Completion in Haematology Inpatients in Aberdeen Royal Infirmary: A Quality Improvement Project | Sophie White | ![]() |
![]() |
|||
122-EP | COVID-19 infection in adult patients with hematological malignancies In Oman | Nema Al Masroori | ![]() |
![]() |
|||
123-EP | Approach to paediatric HLH in 2025: who warrants chemotherapy in the era of immunomodulation ? | Joanna Collins | ![]() |
![]() |
|||
124-EP | Use of incentive spirometry to prevent Acute Chest Syndrome in patients with Sickle Cell Disease | Tasneem Elkanzi | ![]() |
![]() |
|||
125-EP | Role of Therapeutic plasma exchange in Pneumococcal associated Hemolytic uremic syndrome | Nirmalie Fonseka | ![]() |
![]() |
|||
126-EP | Avatrombopag use in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 ADOPT Study | Vickie McDonald | ![]() |
![]() |
|||
127-EP | Retrospective audit on comparison of local practice of ITP management with 2019 international consensus report | Arunodaya Mohan | ![]() |
![]() |
|||
127-PP | Collaborative initiative with the National PNH Service: Survey results from a pegcetacoplan Patient Support Programme | Sana Yaar | ![]() |
![]() |
|||
128-PP | Why would you call an ambulance for a nosebleed? The reality of haemophilia emergency care. | Ranjit Nagra | ![]() |
![]() |
|||
128-EP | A rare case of bone marrow failure syndrome: TERC variant telomeropathy consistent with Dyskeratosis Congenita. | Sumitha Niyomi Nanayakkara | ![]() |
![]() |
|||
129-PP | Injection-Site-Reactions in Adults With Paroxysmal Nocturnal Haemoglobinuria Receiving Subcutaneous Pegcetacoplan for Up to 3 Years | Sana Yaar | ![]() |
![]() |
|||
132-PP | Neutropenic Sepsis in Patients Admitted at SAMOC (Sir Anthony Mamo Oncology Centre) - Malta | Karen Cutajar | ![]() |
![]() |
|||
132-EP | Nurse Led Thromboprophylaxis Service for Women at 28 Weeks Gestation at High Risk of VTE | Jo Webb | ![]() |
![]() |
|||
133-EP | Effectiveness of Iron Carboxymaltose in Maternity Patients for the Treatment of Anaemia | Amy Somerville | ![]() |
![]() |
|||
134-EP | An Audit of Perioperative Transfusion Practices in Pediatric Sickle Cell Disease Patients at Sidra Medicine,Qatar | Salwa Syed Sadaqat Ali | ![]() |
![]() |
|||
135-EP | Alloimmunization in Children with Sickle Cell Disease at Sidra Medicine, Qatar | Salwa Syed Sadaqat Ali | ![]() |
![]() |
|||
137-EP | Isolated Bone Marrow Mastocytosis with hymoneptra allergic reaction | Hansini Dassanayake | ![]() |
![]() |
|||
138-EP | Distribution of MNSs Blood Group Antigens Of Individuals Within Calabar Metropolis, Cross River State, Nigeria DISTRIBUTION OF MNSs BLOOD GROUP ANTIGENS OF INDIVIDUALS WITHIN CALABAR METROPOLIS, CROSS RIVER STATE, NIGERIA. | Joyce Etura | ![]() |
![]() |
|||
139-EP | Comparison of ABO/RhD blood groups distribution among DGH and NHSBT donors over 12 months | Thais Ferrari Gersogamo | ![]() |
![]() |
|||
140-EP | Determining Optimal Haemoglobin Thresholds for Blood Donor Deferral: A Study in a Multi-Ethnic Developing Country | Melissa Friday | ![]() |
![]() |
|||
141-EP | Optimising Albumin Use Across Disciplines at University Hospitals of North Midlands: Quality Improvement Project Report | Syed Aaquil Hasan | ![]() |
![]() |
|||
142-EP | Paediatric Morphology: A Case of Haematological Toxicity Associated with Sodium Valproate | Joanne Hayter | ![]() |
![]() |
|||
143-EP | Assessment of the bodys response to blast injury using haematological ratios. | Inesa Iefimova | ![]() |
![]() |
|||
144-EP | The Application of Autologous Platelet-Rich Fibrin and Platelet-Rich Plasma in Managing a Pathological Mandibular Fracture | Susudu Jayanetti | ![]() |
![]() |
|||
145-EP | Anti-U Antibodies in Pregnancy: Immunohematology Insights. | Gauri Jayasinghe | ![]() |
![]() |
|||
146-EP | Audit on Indications for Therapeutic Plasma Exchange practice in Lady Ridgeway Hospital for Children SriLanka. | Gauri Jayasinghe | ![]() |
![]() |
|||
147-EP | Antibody against high-frequency antigen during pregnancy: Scenario of Anti-Inb antibody in University Hospitals of Leicester. | Gauri Jayasinghe | ![]() |
![]() |
|||
148-EP | Hemolytic Disease of Fetus and Newborn due to Anti Cw and Anti Jka antibodies. | Gauri Jayasinghe | ![]() |
![]() |
|||
148-PP | Clinical Knowledge of Sickle Cell Disease among Doctors at a Tertiary Hospital in West Midlands | Samadhi Wickramasinghe | ![]() |
![]() |
|||
149-EP | Rare Antibody causing Hemolytic Disease of Newborn: Scenario of Anti-Coa in University Hospitals of Leicester. | Gauri Jayasinghe | ![]() |
![]() |
|||
150-EP | Relationship between patient education and knowledge on INR control and INR values in Warfarin Therapy | Chitranga Kariyawasan | ![]() |
![]() |
|||
151-EP | The impact of Serum Ferritin, on HbA2 levels in Thalassemia Screening a single center experience | Chitranga Kariyawasan | ![]() |
![]() |
|||
153-EP | Rituximab-Induced Neutropenia: A Case Report on Effective Use of Buffy Coat Transfusion and GCSF | Narmada Manawasinghe | ![]() |
![]() |
|||
154-EP | A Rare Case of C3d-positive Warm Autoimmune Hemolytic Anemia in a Pediatric Patient | Narmada Manawasinghe | ![]() |
![]() |
|||
155-EP | Reflex testing of intrinsic factor antibody for positive parietal cell antibody in pernicious anaemia | Daisy Metcalfe | ![]() |
![]() |
|||
156-EP | Development of Algorithm and Clinical Decision support system for Laboratory investigation of Thrombocytopenia | sateesh kumar Nagumantry | ![]() |
![]() |
|||
157-EP | Assessing Safety of Blood Donations from Smokers: A Comparative Analysis of Biomarkers and Hematological Parameters | Ifeyinwa Okafor | ![]() |
![]() |
|||
158-EP | Demographic characteristics of blood and blood-components transfusion recipientsand pattern of blood utilization in Nigeria | Henshaw Okoroiwu | ![]() |
![]() |
|||
159-EP | A Case of Thalassemia Intermedia With Alloantibodies Jka and E: Challenges in Transfusion Management | Purshotam Paudel | ![]() |
![]() |
|||
160-EP | Mixed Autoimmune Hemolytic Anemia in Children Managed With Steroids and PRBC Transfusion: a Case Report | Purshotam Paudel | ![]() |
![]() |
|||
161-EP | The Importance of Recognising TACO in the Management of Complex Transfusion Reactions. | Malaika Perchard | ![]() |
![]() |
|||
163-EP | A single centre service evaluation of patient blood management pathways for optimising haemoglobin pre-operatively. | Shashi Rajnarinesingh | ![]() |
![]() |
|||
164-EP | Patterns and Outcomes of Transfusion-dependant -Thalassemia (TDT) Children Over Five Years in Uttarakhand India | Manish Raturi | ![]() |
![]() |
|||
165-EP | Validation of an anti-Xa assay to monitor high heparin concentrations in patients undergoing cardiothoracic surgery. | Claire Rowlandson | ![]() |
![]() |
|||
166-EP | Results of Intrauterine Transfusions in prenatal anemia---Seguridad Transfusional Intrauterina en madres aloinmunizadas y feto con anemia prenatal. | Carolina Carmen Sánchez-Ramos | ![]() |
![]() |
|||
167-EP | Reducing platelet wastage: an audit of platelet use and wastage at Rotherham General Hospital | Andrei Serov | ![]() |
![]() |
|||
168-EP | Comparative Analysis of DNA Concentration Determination for Qualitative and Quantitative Assessment Obtained of Samples | Nataliya Shurko | ![]() |
![]() |
|||
169-EP | Learning from EQA: When the dog bites | Andrea Teuchert | ![]() |
![]() |
|||
170-EP | When to Test for Thrombophilia? Understanding the Implications of Implementing the 2022 Guidelines | Shabnam Banerjee | ![]() |
![]() |
|||
171-EP | Establishing Venous Thromboembolism Prevention Champions at a District General Hospital | Alexandra Butler | ![]() |
![]() |
|||
172-EP | Single site experience of enoxaparin vs unfractionated heparin thromboprophylaxis in patients admitted to renal wards | Rachel Clapham | ![]() |
![]() |
|||
173-EP | Case report: Apixaban Absorption in a Patient with Deep Vein Thrombosis and Previous Gastric Bypass | Rebecca Cloudsdale | ![]() |
![]() |
|||
174-EP | Deep Vein Thrombosis and Nitrous Oxide Abuse: a Case Series | Rebecca Cloudsdale | ![]() |
![]() |
|||
175-EP | INR self-testing revisited: Improving the patient experience in a NHS trust | Niamh Cole | ![]() |
![]() |
|||
176-EP | Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1/VAYHIT2) and Warm Autoimmune Haemolytic Anaemia (VAYHIA) | Devi Prathyusha Nadakuditi | ![]() |
![]() |
|||
177-EP | Immune Thrombocytopenia in a Developing Country: Insights from a Tertiary Care Private Institution | Christopher Ming Yu Foo | ![]() |
![]() |
|||
177-PP | Investigation and Management of Neutropenia Referrals in Area with a High Prevalence of Afro-Caribbean patients | Priya Sriskandarajah | ![]() |
![]() |
|||
178-EP | An in vitro study on prophylactic doses of anticoagulants in coagulation factor deficiencies | Alex Gatt | ![]() |
![]() |
|||
179-PP | Impact of Sickle Cell Disease Patients on Healthcare System; A Single Institutional Retrospective Observational Study | Nadeeka Makewitage | ![]() |
![]() |
|||
179-EP | Single centre experience on direct acting oral anticoagulant levels and clinical outcomes | Richard Hinton | ![]() |
![]() |
|||
180-EP | Anticoagulation treatment ion in Thrombosis management for patients with Myeloproliferative Neoplasms at Whipps Cross Hospital | Nalika Jayasekara | ![]() |
![]() |
|||
181-EP | Anticoagulation Treatment of Patients with Cerebral Venous Sinus Thrombosis | Sashini Mariathasan | ![]() |
![]() |
|||
181-PP | Rare Blood, Rarer Genes: Mumbais First Réunion Phenotype Blood Donor with novel FUT Gene Mutations | Lincy Jacob | ![]() |
![]() |
|||
182-PP | Patient Experience of Treatment Duration Options in Relapsed/Refractory Chronic Lymphocytic Leukaemia: UK Qualitative Study (ELECTRIC) | Dima El-Sharkawi | ![]() |
![]() |
|||
182-EP | The Management of Acute Heparin Induced Thrombocytopenia (HIT) in Patients Listed for Cardiac Transplant | Lindsey McGuire | ![]() |
![]() |
|||
183-EP | Safety Audit of the Off-Label Use of Apixaban in Nephrotic Syndrome. | Jayna Mistry | ![]() |
![]() |
|||
184-EP | Using artificial intelligence to prompt early intervention by thrombosis nurse specialists in acute venous thromboembolism | Kate Musgrave | ![]() |
![]() |
|||
185-EP | Heparin-induced Thrombocytopaenia (HIT)-associated Anaphylactoid Reactions Following Subcutaneous Low Molecular Weight Heparin | William Phipps | ![]() |
![]() |
|||
186-EP | An Audit to Assess Therapeutic Unfractionated Heparin (UFH) for Hospital Adult Inpatients | Clarissa Pui | ![]() |
![]() |
|||
187-EP | A Quarterly Audit to Assess Venous Thromboembolism Prevention Management in Hospital Inpatients | Clarissa Pui | ![]() |
![]() |
|||
188-EP | Testing of Von Willebrand Antigen and Activity in Pregnancy and Labour | Caitlin Rice | ![]() |
![]() |
|||
189-EP | Management of bleeding disorders in pregnant women: a single tertiary-centre experience | Caitlin Rice | ![]() |
![]() |
|||
190-EP | Venous Thromboembolism in Cardiac Surgery: Comparing Emergency with Elective Admissions | Huw Rowswell | ![]() |
![]() |
|||
191-EP | Venous Thromboembolism in Obstetric Patients 2014 2024: Comparison with all VTE events | Huw Rowswell | ![]() |
![]() |
|||
192-EP | Audit of a Multidisciplinary Follow-Up Pathway of Acquired Haemophilia A | Gargi Sharma | ![]() |
![]() |
|||
193-EP | Emicizumab for Multi-Refractory Acquired Haemophilia A | Laith Tafesh | ![]() |
![]() |
|||
194-PP | Using Artificial Intelligence to Identify Patient Emotions Across The Multiple Myeloma Diagnosis and Treatment Journey | Noreen Ali | ![]() |
![]() |
|||
196-PP | Zilovertamab Vedotin Plus R-CHP in Untreated Diffuse Large B-Cell Lymphoma: Phase 2 waveLINE-007 Trial | Charlotte Brennan | ![]() |
![]() |
|||
199-PP | An audit demonstrating a safe and cost-effective model of out-patient intensive chemotherapy for acute leukaemia. | Amy Todd | ![]() |
![]() |
|||
201-PP | A Single-Centre Experience of Methotrexate for the Management of Pure Red Cell and Pure White Cell Aplasia | Laura Batey | ![]() |
![]() |
|||
206-PP | Efficacy and patient satisfaction in ITP patients switching to Avatrombopag from Eltrombopag or Romiplostim | Peyman Adjamian | ![]() |
![]() |
|||
208-PP | Pharmacokinetic and Efficacy Assessment of a New Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency | Eugenio Rosado | ![]() |
![]() |
|||
213-PP | Practical Insights into Managing Iron Deficiency Anaemia at UCLH | Kate OConnell | ![]() |
![]() |
|||
218-PP | Machine Learning-Based Prediction of Hospitalization Risk in Multiple Myeloma Patients | Ceri Bygrave | ![]() |
![]() |
|||
220-PP | A Randomised Trial of Intermediate-Dose Heparin versus Standard-Dose Thromboprophylaxis in Critically Ill Patients with COVID-19 | Charlotte Bradbury | ![]() |
![]() |
|||
224-PP | Involving patients in the development of a Patient Initiated Follow up (PIFU) scheme in Wales | Charlotte bloodworth | ![]() |
![]() |
|||
226-PP | Characterisation of Clinically Significant Breakthrough Haemolysis in Patients With Paroxysmal Nocturnal Haemoglobinuria Treated With Pegcetacoplan | Sana Yaar | ![]() |
![]() |
|||
237-PP | Sickle cell trait as a hematological contribution to vascular cognitive impairment and dementia: | Hyacinth Hyacinth | ![]() |
![]() |
|||
273-PP | Evaluating Adherence to Updated BSH and NICE Guidelines for Polycythaemia Vera and Secondary Erythrocytosis Management. | Kashif Waqas | ![]() |
![]() |
|||
291-PP | Low Rates of Utilisation of CNS-directed Prophylaxis in Diffuse Large B-cell Lymphoma: Measuring the Impact | Samuel Wiltshire | ![]() |
![]() |
|||
293-PP | Clinical Outcomes for Patients Receiving First-line Pola-R-CHP for Large B-cell Lymphoma Treated at Gloucestershire Hospitals | Mahina Baloch | ![]() |
![]() |
|||
307-PP | The utility of bone marrow assessment in Consultative Haematology | Tendaishe Mutize | ![]() |
![]() |
|||
340-PP | Herpes zoster incidence rates in adults with haematological malignancies: a retrospective cohort study (20122019) | Lyes Derouiche | ![]() |
![]() |
|||
353-PP | Anticoagulation Decisions at the End of Life: A Survey of UK Clinicians. | Thomas Shevlin | ![]() |
![]() |
|||
354-PP | Reporting haemostasis assays in IU/dL: recommendations from the BSH, UKHCDO and UK NEQAS (Blood Coagulation) | Ian Jennings | ![]() |
![]() |
|||
357-PP | Efanesoctocog Alfa in Adults/Adolescents with Haemophilia A: European Results from the XTEND-ed Second Interim Analysis | Jayashree Motwani | ![]() |
![]() |
|||
362-PP | Impact of updated guidance and implementation of a local Pulmonary Embolism Response Team (PERT) | Lara Roberts | ![]() |
![]() |
|||
377-PP | Duration of Caplacizumab Therapy for Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) | Rebecca J Shaw | ![]() |
![]() |
|||
383-PP | Simultaneous IgG and IgM Platelet Antibodies Causing Acquired Thrombocytopenia, Platelet Clumping and Spontaneous Bleeding | Rebecca J Shaw | ![]() |
![]() |
|||
389-PP | A UK review of the treatment of idiopathic multicentric Castlemans disease (iMCD) with siltuximab | Janine Qasim | ![]() |
![]() |
|||
398-PP | What Bacteria Cause Central Line-associated Bloodstream Infections in a Paediatric Population of Haemophilia? | Aditya Chezhian | ![]() |
![]() |
|||
400-PP | Impact of Nursing Engagement to Improving Fever-to-Needle Time in St. Bartholomews Hospital Haematology-Oncology Department | Greal Huypungco | ![]() |
![]() |
|||
406-PP | The Efficacy and Safety of Avatrombopag for the Treatment of Children with Immune Thrombocytopenia (AVA-PED-301) | Peyman Adjamian | ![]() |
![]() |
|||
432-PP | The Use of Cellavision to Facilitate The Referral of Blood Films to the Consultant Haematologist | Robert Grainger | ![]() |
![]() |
|||
437-PP | Real-World Treatment Outcomes of Venetoclax in Acute Myeloid Leukemia in Great Britain (ARC) | Hanna Kew | ![]() |
![]() |
|||
441-PP | RADAR: An International Trial Comparing ABVD with Brentuximab Vedotin plus AVD in Limited-Stage Hodgkin Lymphoma | Pip Patrick | ![]() |
![]() |
|||
445-PP | Real-Time Monitoring of Pain Variability in Sickle Cell Disease: Patient-Reported Outcome Links to Vaso-Occlusive Crises | Kim Summers | ![]() |
![]() |
|||
446-PP | Efficacy/Safety of the BTK Degrader NX-5948 in Waldenström macroglobulinemia: An Ongoing Phase 1a/b Study | Lee Miller | ![]() |
![]() |
|||
449-PP | Audit on Improving the Diagnosis and Management of Haemophagocytic lymphohistiocytosis (HLH) at Leeds Teaching Hospitals. | Amany Ihab Mohamed | ![]() |
![]() |
|||
453-PP | Pathology Portal in Haematology Training: a Tool to Standardise and Harmonise Morphology Skills across UK. | Amany Ihab Mohamed | ![]() |
![]() |
|||
456-PP | Comparison of pre and post treatment concerns for Lymphoma patients at a London NHS Trust. | Karen Stanley | ![]() |
![]() |
|||
462-PP | Epcoritamab Monotherapy for Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From EPCORE NHL-1 | Kayla Smull | ![]() |
![]() |
|||
464-PP | Learning from Experience: The Use of Andexanet Alfa in the Management of Life-Threatening Gastrointestinal Bleeding | Sarah Wheeldon | ![]() |
![]() |
|||
466-PP | Fixed-Duration Epcoritamab R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: EPCORE NHL-2 Update | Kayla Smull | ![]() |
![]() |
|||
468-PP | Fixed-Duration Epcoritamab R-Mini-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: EPCORE NHL-2 Update | Kayla Smull | ![]() |
![]() |
|||
481-PP | Real-Time Treatment Impact Tracking: Implications for the Feasibility of Remote Digital Monitoring in Waldenstrom Macroglobulinemia | Kim Summers | ![]() |
![]() |
|||
497-PP | SECURE Study: Incidentally Detected MGUS Patients Have Comparable Depression Anxiety Rates to UK General Population | Elizabeth Knight | ![]() |
![]() |
27-29 April Glasgow
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|